Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum

By Takagi M.   Mochida H.   Noto T.   Yano K.   Inoue H.   Ikeo T.   Kikkawa K.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

FR226807: a potent and selective phosphodiesterase type 5 inhibitor

By Hosogai N.   Hamada K.   Tomita M.   Nagashima A.   Takahashi T.   Sekizawa T.   Mizutani T.   Urano Y.   Kuroda A.   Sawada K.   Ozaki T.   Seki J.   Goto T.  

European Journal of Pharmacology, Vol. 428, Iss. 2, 2001-10 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5

By Hirose R.   Okumura H.   Yoshimatsu A.   Irie J.   Onoda Y.   Nomoto Y.   Takai H.   Ohno T.   Ichimura M.  

European Journal of Pharmacology, Vol. 431, Iss. 1, 2001-11 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vitro

By Taniguchi H.   Yazaki N.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 304, Iss. 1, 1996-05 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of T-0632, a novel potent and selective CCK A receptor antagonist, in vivo

By Taniguchi H.   Yazaki N.   Yomota E.   Shikano T.   Endo T.   Nagasaki M.  

European Journal of Pharmacology, Vol. 312, Iss. 2, 1996-09 ,pp. : 227-233

Elsevier

Access to resources Recommend Favorite